Literature DB >> 23319288

Strategic applications of gene expression: from drug discovery/development to bedside.

Jane P F Bai1, Alexander V Alekseyenko, Alexander Statnikov, I-Ming Wang, Peggy H Wong.   

Abstract

Gene expression is useful for identifying the molecular signature of a disease and for correlating a pharmacodynamic marker with the dose-dependent cellular responses to exposure of a drug. Gene expression offers utility to guide drug discovery by illustrating engagement of the desired cellular pathways/networks, as well as avoidance of acting on the toxicological pathways. Successful employment of gene-expression signatures in the later stages of drug development depends on their linkage to clinically meaningful phenotypic characteristics and requires a biologically meaningful mechanism combined with a stringent statistical rigor. Much of the success in clinical drug development is hinged on predefining the signature genes for their fitness for purposes of application. Specific examples are highlighted to illustrate the breadth and depth of the potential utility of gene-expression signatures in drug discovery and clinical development to targeted therapeutics at the bedside.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23319288      PMCID: PMC3675744          DOI: 10.1208/s12248-012-9447-1

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   3.603


  96 in total

1.  mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities.

Authors:  Hongfang Liu; Petula D'Andrade; Stephanie Fulmer-Smentek; Philip Lorenzi; Kurt W Kohn; John N Weinstein; Yves Pommier; William C Reinhold
Journal:  Mol Cancer Ther       Date:  2010-05-04       Impact factor: 6.261

Review 2.  Translating the COPD transcriptome: insights into pathogenesis and tools for clinical management.

Authors:  Julie E Zeskind; Marc E Lenburg; Avrum Spira
Journal:  Proc Am Thorac Soc       Date:  2008-12-01

3.  Identifying siRNA-induced off-targets by microarray analysis.

Authors:  Emily Anderson; Queta Boese; Anastasia Khvorova; Jon Karpilow
Journal:  Methods Mol Biol       Date:  2008

4.  Identification of proteasome gene regulation in a rat model for HIV protease inhibitor-induced hyperlipidemia.

Authors:  Jeffrey F Waring; Rita Ciurlionis; Kennan Marsh; Larry L Klein; David A Degoey; John T Randolph; Brian Spear; Dale J Kempf
Journal:  Arch Toxicol       Date:  2010-03-06       Impact factor: 5.153

Review 5.  Genetic toxicology in the 21st century: reflections and future directions.

Authors:  Brinda Mahadevan; Ronald D Snyder; Michael D Waters; R Daniel Benz; Raymond A Kemper; Raymond R Tice; Ann M Richard
Journal:  Environ Mol Mutagen       Date:  2011-04-28       Impact factor: 3.216

6.  Changes in articular cartilage and subchondral bone histomorphometry in osteoarthritic knee joints in humans.

Authors:  Dragica Bobinac; Josip Spanjol; Sanja Zoricic; Ivana Maric
Journal:  Bone       Date:  2003-03       Impact factor: 4.398

7.  Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease.

Authors:  Joel T Dudley; Marina Sirota; Mohan Shenoy; Reetesh K Pai; Silke Roedder; Annie P Chiang; Alex A Morgan; Minnie M Sarwal; Pankaj Jay Pasricha; Atul J Butte
Journal:  Sci Transl Med       Date:  2011-08-17       Impact factor: 17.956

8.  Genetics of gene expression and its effect on disease.

Authors:  Valur Emilsson; Gudmar Thorleifsson; Bin Zhang; Amy S Leonardson; Florian Zink; Jun Zhu; Sonia Carlson; Agnar Helgason; G Bragi Walters; Steinunn Gunnarsdottir; Magali Mouy; Valgerdur Steinthorsdottir; Gudrun H Eiriksdottir; Gyda Bjornsdottir; Inga Reynisdottir; Daniel Gudbjartsson; Anna Helgadottir; Aslaug Jonasdottir; Adalbjorg Jonasdottir; Unnur Styrkarsdottir; Solveig Gretarsdottir; Kristinn P Magnusson; Hreinn Stefansson; Ragnheidur Fossdal; Kristleifur Kristjansson; Hjortur G Gislason; Tryggvi Stefansson; Bjorn G Leifsson; Unnur Thorsteinsdottir; John R Lamb; Jeffrey R Gulcher; Marc L Reitman; Augustine Kong; Eric E Schadt; Kari Stefansson
Journal:  Nature       Date:  2008-03-16       Impact factor: 49.962

Review 9.  Surrogate tissue analysis: monitoring toxicant exposure and health status of inaccessible tissues through the analysis of accessible tissues and cells.

Authors:  John C Rockett; Michael E Burczynski; Albert J Fornace; Paul C Herrmann; Stephen A Krawetz; David J Dix
Journal:  Toxicol Appl Pharmacol       Date:  2004-01-15       Impact factor: 4.219

10.  The possible role of hematopoietic cell kinase in the pathophysiology of COPD.

Authors:  Satoru Yanagisawa; Hisatoshi Sugiura; Tomonori Yokoyama; Toshiyuki Yamagata; Tomohiro Ichikawa; Keiichirou Akamatsu; Akira Koarai; Tsunahiko Hirano; Masanori Nakanishi; Kazuto Matsunaga; Yoshiaki Minakata; Masakazu Ichinose
Journal:  Chest       Date:  2008-08-21       Impact factor: 9.410

View more
  7 in total

Review 1.  Personalized radiotherapy: concepts, biomarkers and trial design.

Authors:  A H Ree; K R Redalen
Journal:  Br J Radiol       Date:  2015-05-20       Impact factor: 3.039

Review 2.  Next-Generation Sequencing: The Translational Medicine Approach from "Bench to Bedside to Population".

Authors:  Mohammad Muzafar Beigh
Journal:  Medicines (Basel)       Date:  2016-06-02

3.  Time Course Expression Analysis of 1[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole Induction of Cytoprotection in Human Endothelial Cells.

Authors:  James A Bynum; Xinyu Wang; Salomon A Stavchansky; Phillip D Bowman
Journal:  Gene Regul Syst Bio       Date:  2017-04-07

4.  Gene Signature-Based Approach Identified MEK1/2 as a Potential Target Associated With Relapse After Anti-TNFα Treatment for Crohn's Disease.

Authors:  Kanae Gamo; Yuumi Okuzono; Masato Yabuki; Takashi Ochi; Kyoko Sugimura; Yosuke Sato; Masaki Sagara; Hiroki Hayashi; Yoshimasa Ishimura; Yutaka Nishimoto; Yusuke Murakawa; Zenyu Shiokawa; Masayuki Gotoh; Takahiro Miyazaki; Yukihiko Ebisuno
Journal:  Inflamm Bowel Dis       Date:  2018-05-18       Impact factor: 5.325

5.  Influence of storage conditions of small volumes of blood on immune transcriptomic profiles.

Authors:  Rebecca Mathew; Mohammed Toufiq; Valentina Mattei; Muna Al Hashmi; Harshitha Shobha Manjunath; Basirudeen Syed Ahamed Kabeer; Rita Calzone; Chiara Cugno; Damien Chaussabel; Sara Deola; Sara Tomei
Journal:  BMC Res Notes       Date:  2020-03-13

6.  Consensus clustering for Bayesian mixture models.

Authors:  Stephen Coleman; Paul D W Kirk; Chris Wallace
Journal:  BMC Bioinformatics       Date:  2022-07-21       Impact factor: 3.307

7.  In silico prediction of novel therapeutic targets using gene-disease association data.

Authors:  Enrico Ferrero; Ian Dunham; Philippe Sanseau
Journal:  J Transl Med       Date:  2017-08-29       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.